Lantheus Holdings acquired Evergreen Theragnostics and Life Molecular Imaging, and plans to divest a SPECT segment.
1 report, 1 independent
Updated Jun 30
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Lantheus Holdings acquired Evergreen Theragnostics and Life Molecular Imaging, and plans to divest a SPECT segment.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
Coverage
Newest first; wire copies grouped- Insider MonkeyRiley Maintains ‘Buy’ Rating on Lantheus Holdings, Inc. (LNTH); Lowers PT Lantheus Holdings, Inc. (NASDAQ:LNTH) is one of the best stocks for a Growth Stock Portfolio. A pharmacist in their lab coat